« Previous
Seminars in Perinatology
Volume 31, Issue 6
, Pages 372-377
, December 2007
Contraception for the Transplant Patient
References
- OPTN Data. Available at: http://www.optn.org/latestData/rptData.asp
- WHO Medical Eligibility for Contraceptive Use. (3rd ed).. 2004;Geneva, Switzerland. Available at: http://www.who.int/reproductive-health/publications/mec/mec.pdf
- Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med. 1981;26:99–102
- . Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75(suppl 1):S16–S30
- Micromedex® Drug Monographs. Greenwood Village, CO: Thomson Micromedex; 2004;
- . How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators. Eur J Immunol. 2005;35:3396–3399
- Is the intrauterine device appropriate contraception for HIV-1 infected women?. Br J Obstet Gynaecol. 2001;108:784–790
- . Serum and peritoneal fluid levles of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril. 2005;83:398–404
- The significance of bleeding patterns in Norplant implant users. Obstet Gynecol. 1993;77:256–265
- WHO Medical Eligibility Criteria for Contraception. 2006;
- Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adoles Med. 2005;159:139–144
- Safety and efficacy of Implanon- a single rod implantable contraceptive containing etonorgestrel. Contraception. 2005;71:319–326
- . Gastrointestinal metabolism of contraceptive steroids. Am J Obstet Gynecol. 1990;163:2138–2145
- Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest. 1987;80:1029–1036
- . Effect of an oral contraceptive on the circulating levels of budesonide and prednisolone and the influence on plasma cortisol. Clin Pharmacol Ther. 2000;67:373–381
- Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol. 2001;98:853–860
- Combined oral contraception in women after renal transplantation. Neuro Endocrinol Lett. 2006;27:679–682
- . Gynecologicc health care for the adolescent solid organ transplant recipient. Pediatr Transplant. 2005;9:346–356
- Comparison of ethinyl estradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contracpetive. Contraception. 2005;72:168–174
- Venous thromboembolism, myocardial infarction and stroke among transdermal contraceptive system users. Obstet Gynecol. 2007;109:339–346
- Risk of nonfatal venous thromboembolism in women using a transdermal contraceptive patch and an oral contraceptive containing norgestimate and 35 mcgm of ethinyl estradiol. Contraception. 2006;73:223–228
- Further results on the risk of nonfatal venous thromboembolism in women using a transdermal contraceptive patch and an oral contraceptive containing norgestimate and 35 mcgm of ethinyl estradiol. Contraception. 2007;76:4–7
- Contraceptive Technology. (18th ed).. New York, NY: Ardent Media; 2004;
PII: S0146-0005(07)00111-5
doi: 10.1053/j.semperi.2007.09.007
© 2007 Elsevier Inc. All rights reserved.
« Previous
Seminars in Perinatology
Volume 31, Issue 6
, Pages 372-377
, December 2007
